Investor Relations

Company Overview

Augmedix, Inc. (Augmedix Nasdaq: AUGX) provides automated medical documentation and data services to large healthcare systems and physician practices, supporting medical offices, clinics, hospitals, emergency departments and telemedicine nationwide. The Company’s Ambient Automation Platform converts the natural conversation between physicians and patients into timely and comprehensive medical notes and performs a suite of related data services. These services relieve physicians of administrative burdens to enable more time for patient care. Augmedix’s proprietary platform uses automatic speech recognition, natural language processing and clinical datasets to capture the ambient visit conversation and generate a structured medical note. The structured medical note data is then used to deliver additional data services. Quality is assured by trained medical documentation specialists.

Latest Financial Results

Q2 2022

Quarter Ended June 30, 2022

Latest Annual Filing

For Fiscal Year Ending December 31, 2021

IR Contacts

Headquarters

Augmedix, Inc.
111 Sutter St.
Suite 1300
San Francisco, CA 94104

Investor Relations

Caroline Paul
investors@augmedix.com

Transfer Agent

Vstock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
info@vstocktransfer.com